There is also evidence of the decline in plasma levels of MIG, IP-10, GM-CSF, and IFN-γ corresponding with successful TB treatment, whereas levels of CCL2 and CCL11 increased with successful TB treatment in PTB patients25. The gene discussed is CCL2; the disease is tuberculosis.